Regeneration/Tutogen Merger Creates Broad Biologic Implant Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Regeneration Technologies Inc. will maintain both the BioCleanse and Tutoplast tissue sterilization processes for making biologic implants following its acquisition of Tutogen in a $263 million stock-swap deal, announced Nov. 13
You may also be interested in...
People In Brief
New SpectraScience board: The light-based biopsy system maker announced Jan. 12 that is has established an advisory board chaired by former Wisconsin Governor and Health and Human Services Secretary Tommy Thompson to "assist and direct management in facing requirements of a changing health care system." SpectraScience markets the WavSTAT optical biopsy system and the LUMA cervical imaging tool. [Editor's note: The original version of this brief incorrectly identified the company creating the new advisory board.
People In Brief
New SpectraScience board: The light-based biopsy system maker announced Jan. 12 that is has established an advisory board chaired by former Wisconsin Governor and Health and Human Services Secretary Tommy Thompson to "assist and direct management in facing requirements of a changing health care system." SpectraScience markets the WavSTAT optical biopsy system and the LUMA cervical imaging tool. [Editor's note: The original version of this brief incorrectly identified the company creating the new advisory board.
People In Brief
Kennedy rises at Viking: John "Jed" Kennedy is the new CEO of 2D and 3D visualization system manufacturer Viking Systems, effective Jan. 4. Kennedy has been president and chief operating officer at the company since October 2007 and was president of Viking's Vision Systems Group prior to that. Kennedy has also worked at Vista Medical and Smith & Nephew